NCT01258088View on ClinicalTrials.gov

Safety Study of Ointment for the Treatment of Plaque-type Psoriasis

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 7, 2010

Study Completion Date

December 7, 2010

Conditions

Plaque-type Psoriasis

Interventions

DRUG

AN2728 Ointment

5mg/cm2, BID

DRUG

AN2728 Vehicle

5mg/cm2 BID

Trial Locations (1)

5000

CMAX (A Division of IDT Australia Ltd), Adelaide

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT01258088 - Safety Study of Ointment for the Treatment of Plaque-type Psoriasis | Biotech Hunter | Biotech Hunter